| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/27/1993 | EP0524639A2 Process for the labelling of substances with technetium or rhenium |
| 01/27/1993 | EP0524604A2 Process for the preparations of S-(+)-2,2-dimethyl-cyclopropane carboxamid by genetically engineered microorganismes |
| 01/27/1993 | EP0524584A2 Method for the preparation of high-affinity hapten-specific antibodies and a composition for the detection of haptens |
| 01/27/1993 | EP0524583A1 Procedure and means for the turbidimetric or nephelometric determination of analyses |
| 01/27/1993 | EP0524553A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |
| 01/27/1993 | EP0524421A1 Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use |
| 01/27/1993 | EP0524360A1 A somatotropin-based improved process for the farming of salmonids, particularly in seawater |
| 01/27/1993 | EP0524260A1 GPIb$g(a) FRAGMENTS AND RECOMBINANT DNA EXPRESSION VECTORS |
| 01/27/1993 | EP0524254A1 A binary genetic system to control expression of a transgene in a transgenic animal |
| 01/27/1993 | EP0348442B1 Altered antibody |
| 01/27/1993 | CN1068335A Hepatitis c diagnostics and vaccines |
| 01/27/1993 | CN1068334A Peptides useful in regulating immune and nervous systems |
| 01/27/1993 | CN1068266A Vaccine and treatment method for human immunodeficiency virus |
| 01/27/1993 | CA2074590A1 Process for the production of high affinity anti-hapten antibodies and composition for the determination of haptens |
| 01/27/1993 | CA2074547A1 Activator gene for macrolide biosynthesis |
| 01/27/1993 | CA2074538A1 Vectors |
| 01/26/1993 | US5182375 DNA encoding follistatin |
| 01/26/1993 | US5182369 Method for purifying somatotropin monomers |
| 01/26/1993 | US5182368 Lymphokines, antibodies |
| 01/26/1993 | US5182367 5-lipoxygenase activating protein |
| 01/26/1993 | US5182364 Polypeptide analogs of apolipoprotein E |
| 01/26/1993 | US5182263 Analogs of tyrosine sulfate or tyrosine phosphate containing peptides |
| 01/26/1993 | US5182262 Polypeptides which mediate immune responses and may be useful in preventing organ transplant rejection |
| 01/26/1993 | US5182261 Modified transforming growth factor alpha oligopeptides and pharmaceutical compositions thereof |
| 01/26/1993 | US5182260 Dna sequences encoding snake venom inhibitors of platelet activation processes for producing those inhibitors and compositions using them |
| 01/26/1993 | US5182257 Anticarcinogenic agents |
| 01/26/1993 | US5182211 Vaccines |
| 01/26/1993 | US5182205 Lymphocytes |
| 01/26/1993 | US5182200 Promotion of transcription in plants |
| 01/26/1993 | US5182196 Expression systems for overproduction of desired proteins |
| 01/26/1993 | US5182195 Method for increasing gene expression using protease deficient yeasts |
| 01/26/1993 | US5182113 Factor xa inibitor from leech and pharmaceutical compositions containing same |
| 01/26/1993 | US5182107 Delivering nerve growth factor across blood brain barrier to brain |
| 01/26/1993 | CA2074626A1 Prophylaxis and treatment of adverse oral conditions with biologically active peptides |
| 01/26/1993 | CA1313157C Gastrin releasing peptide antagonist |
| 01/26/1993 | CA1313152C Enhancing dna sequences |
| 01/26/1993 | CA1313151C Vaccine against rinderpest virus using recombinant vaccinia virus |
| 01/25/1993 | CA2070751A1 Proteins |
| 01/24/1993 | CA2074345A1 Method and agent for the turbidimetric or nephelometric determination of analytes |
| 01/23/1993 | WO1993001837A1 Conjugated moieties for chelating paramagnetic metals |
| 01/23/1993 | CA2074394A1 Somatotropin-based improved process for the farming of salmonids, particularly in seawater |
| 01/21/1993 | WO1993001316A1 Differentiation of htlv-i and htlv-ii using synthetic peptides |
| 01/21/1993 | WO1993001315A1 PEN POLYMORPHISM OF HUMAN PLATELET MEMBRANE GLYCOPROTEIN IIIa AND DIAGNOSTIC AND THERAPEUTIC APPLICATION THEREOF |
| 01/21/1993 | WO1993001314A1 DNAs ENCODING PROTEINS ACTIVE IN LYMPHOCYTE-MEDIATED CYTOTOXICITY |
| 01/21/1993 | WO1993001305A1 A method for the identification of protease inhibitors |
| 01/21/1993 | WO1993001304A1 Synthetic peptides related to fiv-env proteins |
| 01/21/1993 | WO1993001301A1 Mutant antiviral regulatory proteins |
| 01/21/1993 | WO1993001300A1 Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules |
| 01/21/1993 | WO1993001297A1 Recombinant adenoviruses for detection of specific trans-acting gene function |
| 01/21/1993 | WO1993001291A1 Herpes virus proteinase and method of assaying |
| 01/21/1993 | WO1993001288A1 Phagemide for screening antibodies |
| 01/21/1993 | WO1993001287A1 Recombinant antibodies at the surface of e. coli |
| 01/21/1993 | WO1993001284A1 Recombinant viral vaccine |
| 01/21/1993 | WO1993001282A1 Novel mutagenesis methods and compositions |
| 01/21/1993 | WO1993001279A1 Recombinant hepatitis a virus vaccine |
| 01/21/1993 | WO1993001275A1 NOVEL GROWTH FACTOR-RESPONSIVE PROGENITOR CELLS WHICH CAN BE PROLIFERATED $i(IN VITRO) |
| 01/21/1993 | WO1993001274A1 Method for producing recombinant proteins and host cells used therein |
| 01/21/1993 | WO1993001273A1 Screening method for chronic fatigue syndrome |
| 01/21/1993 | WO1993001241A1 Use of unpigmented fish skin, particularly from flat fish, as a novel industrial source of collagen, extraction method, and collagen and biomaterial thereby obtained |
| 01/21/1993 | WO1993001214A1 Recombinant human interleukin 6 with homogeneous n-terminus and production thereof |
| 01/21/1993 | WO1993001213A1 Allergenic proteins and peptides from japanese cedar pollen |
| 01/21/1993 | WO1993001212A1 Cysteine depleted il-6 muteins |
| 01/21/1993 | WO1993001211A1 Peptide which abrogates tnf and/or lps toxicity |
| 01/21/1993 | WO1993001209A1 Proteins s polypeptides and uses thereof |
| 01/21/1993 | WO1993001207A1 Process for the purification of serum albumin |
| 01/21/1993 | WO1993001206A1 Conformationally restricted biologically active peptides, methods for their production and uses thereof |
| 01/21/1993 | WO1993001205A1 Tyrosine kinase |
| 01/21/1993 | WO1993000926A1 Treatment of periodontal disease with protease inhibitors |
| 01/21/1993 | WO1993000923A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 01/21/1993 | WO1993000920A1 Use of interleukine 10 to produce drugs with a tumour-inhibiting action |
| 01/21/1993 | WO1993000917A1 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis |
| 01/21/1993 | WO1993000909A1 Method and assay system for neurotrophin activity |
| 01/21/1993 | WO1992020806A3 Dictyostelid expression vector and method for expressing a desired protein |
| 01/21/1993 | WO1992017566A3 Methods for selection of recombinant host cells expressing high levels of a desired protein |
| 01/21/1993 | DE4205148A1 Monoklonale antikoerper gegen c-kit Monoclonal antibodies against c-kit |
| 01/21/1993 | CA2113190A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 01/21/1993 | CA2113076A1 Recombinant human interleukin 6 with homogeneous n-terminus and production thereof |
| 01/21/1993 | CA2112913A1 Allergenic proteins and peptides from japanese cedar pollen |
| 01/21/1993 | CA2112799A1 Method and assay system for neurotrophin activity |
| 01/21/1993 | CA2112748A1 A protein kinase associated with dna repair activity |
| 01/21/1993 | CA2112473A1 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis |
| 01/21/1993 | CA2112468A1 Dnas encoding proteins active in lymphocyte-mediated cytotoxicity |
| 01/21/1993 | CA2112255A1 Herpes virus proteinase and method of assaying |
| 01/21/1993 | CA2111327A1 Cysteine depleted il-6 muteins |
| 01/21/1993 | CA2110992A1 Production process for recombinant proteins and host cells used |
| 01/20/1993 | EP0523976A2 Manipulation of gene copy number in bordetella |
| 01/20/1993 | EP0523949A1 Production of antibodies |
| 01/20/1993 | EP0523675A1 Inhibitory agent against HIV superinfection |
| 01/20/1993 | EP0523395A2 Seroreactive domains from the HPV 16 E1 and E2 proteins |
| 01/20/1993 | EP0523391A1 Use of HPV-16 E6 and E7-gene derived peptides for the diagnostic purpose |
| 01/20/1993 | EP0523187A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 01/20/1993 | EP0523140A1 Reagents and methods for modulating gene expression through rna mimicry |
| 01/20/1993 | EP0523056A1 Neutralizing and/or adcc mediating monoclonal hiv antibody |
| 01/20/1993 | EP0379511B1 Polypeptides with laminin activity |
| 01/20/1993 | EP0359739B1 Tranforming growth factor-beta |
| 01/20/1993 | CN1068123A Superactive grf analogs |
| 01/20/1993 | CA2074113A1 Organic compounds |
| 01/19/1993 | USRE34165 Pentapeptide immunoregulators |
| 01/19/1993 | US5180820 Nucleic acid sequence code |
| 01/19/1993 | US5180813 Early envelope glycoprotein of human cytomegalovirus (hmcv) and monoclonal antibodies to the glycoproteins |